INTERMITTENT TOPICAL TREATMENT OF PSORIASIS WITH BETAMETHASONE DIPROPIONATE 0.05 PERCENT CREAM

被引：0
|
作者：
VANDIJK, E
BAKKERS, EJM
GO, MJ
MONTNOR, LP
ROESSEL, FE
VANDERWATEREN, AR
WUITE, J
机构：
[1] DIACONESSENHUIS, DEPT DERMATOL, NAARDEN, NETHERLANDS
[2] DE WEVER HOSP, DEPT DERMATOL, HEERLEN, NETHERLANDS
[3] ST LAMBERTUS HOSP, DEPT DERMATOL, HELMOND, NETHERLANDS
[4] AMSTELVEEN HOSP, DEPT DERMATOL, HAARLEM, NETHERLANDS
[5] MARIA STICHTING HOSP, DEPT DERMATOL, HAARLEM, NETHERLANDS
来源：
CUTIS | 1983年 / 32卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：284 / +
页数：1
相关论文
共 50 条
  • [21] Calcipotriol/betamethasone dipropionate for the treatment of psoriasis
    Charakida, A
    Dadzie, O
    Teixeira, F
    Charakida, M
    Evangelou, G
    Chu, AC
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (05) : 597 - 606
  • [22] Efficacy and Safety of Topical Calcipotriol Plus Betamethasone Dipropionate Versus Topical Betamethasone Dipropionate Alone in Mild to Moderate Psoriasis
    Sindhuja, M.
    Muthiah, N. S.
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (23A) : 28 - 38
  • [23] STRIAE AND PERSISTENT TINEA-CORPORIS RELATED TO PROLONGED USE OF BETAMETHASONE DIPROPIONATE 0.05-PERCENT CREAM-CLOTRIMAZOLE 1-PERCENT CREAM (LOTRISONE CREAM)
    BARKEY, WF
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1987, 17 (03) : 518 - 519
  • [24] Topical calcipotriol plus betamethasone dipropionate for the treatment of plaque psoriasis: a drug evaluation
    Purvis, Caitlin G.
    Balogh, Esther A.
    Heron, Courtney E.
    Feldman, Steven R.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (09) : 1107 - 1117
  • [25] EVALUATING THE EFFICIENCY OF CALCIPOTRIOL PLUS BETAMETHASONE DIPROPIONATE CUTANEOUS PAD CREAM FOR THE TOPICAL TREATMENT OF MILD TO MODERATE PLAQUE PSORIASIS IN ITALY
    Prignano, F.
    Campanati, A.
    Banerjee, R.
    Carles, A.
    Galvan, J.
    Lorenzo-Herrero, S.
    Crespo, C.
    Cuervo, J.
    VALUE IN HEALTH, 2024, 27 (12) : S82 - S82
  • [26] DIFLORASONE DIACETATE OINTMENT 0.05-PERCENT VERSUS BETAMETHASONE DIPROPIONATE OINTMENT 0.05-PERCENT IN MODERATE-SEVERE PLAQUE-TYPE PSORIASIS
    SHUPACK, JL
    JONDREAU, L
    KENNY, C
    STILLER, MJ
    DERMATOLOGY, 1993, 186 (02) : 129 - 132
  • [27] Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematic review
    Yan, Ru
    Jiang, Shibin
    Wu, Yan
    Gao, Xing-Hua
    Chen, Hong-Duo
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2016, 82 (02): : 135 - 144
  • [28] Betamethasone Dipropionate Spray 0.05% Alleviates Troublesome Symptoms of Plaque Psoriasis
    Gold, Linda Stein
    Bagel, Jerry
    Allenby, Kent
    Sidgiddi, Srinivas
    CUTIS, 2020, 105 (02): : 97 - +
  • [29] Effective treatment of severe nail psoriasis using topical calcipotriol with betamethasone dipropionate gel
    Tan, Eugene Sern-Ting
    Oon, Hazel Hwee-Boon
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2016, 82 (03): : 345 - U202
  • [30] DFD-01: a novel topical formulation of betamethasone dipropionate for the treatment of extensive psoriasis
    Yamauchi, Paul
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (02) : 85 - 91
12345